This follows an earlier notice dated November 25, 2024, from Nasdaq to Molecular Templates, highlighting non-compliance with Nasdaq Listing Rule 5250(c)(1) due to the failure to file its Quarterly ...
Molecular Templates, Inc. (NASDAQ:MTEM), a pharmaceutical company with a market capitalization of just $2.34 million, has been notified of its pending delisting from the Nasdaq Stock Market. The ...
Molecular Templates, Inc. (NASDAQ:MTEM), a pharmaceutical company with a market capitalization of just $2.34 million, has been notified of its pending delisting from the Nasdaq Stock Market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback